Frank Clyburn
Chief Executive Officer, International Flavors & Fragrances.
Companies
- Kailera Therapeutics, Inc.Board member Apr 16, 2026 to now1
- CencoraBoard member Oct 1, 2024 to now2
- Revolution Medicines (United States)Board member Aug 7, 2024 to now3
- International Flavors & FragrancesChief executive officer Feb 18, 2022 to Mar 5, 20244
- Merck & Co.EVP, Chief Commercial Officer Jan 10, 2019 to Nov 4, 20215
- DuPontBoard member Jun 5, 2019 to Apr 30, 20216
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Merck & Co. MRK98,875 shares7$14.7M at $149.02Nov 2, 2021- Revolution Medicines (United States) RVMD10,929 shares8$2.0M at $182.09Jun 18, 2026
Cencora COR1,724 shares9$586.3K at $340.08Mar 5, 2026
International Flavors & Fragrances IFF1,847 shares10$168.0K at $90.97Mar 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 18, 2026Granted 1,191 shares of Revolution Medicines (United States)8
- Mar 5, 2026Granted 557 shares at $359.28 of Cencora9
- Jun 26, 2025Granted 2,806 shares of Revolution Medicines (United States)11
- Mar 11, 2025L 4 shares at $260.69 of Cencora12
- Mar 6, 2025Granted 789 shares of Cencora13
- Nov 1, 2024Granted 368 shares at $234.27 of Cencora14
- Aug 5, 2024Granted 6,932 shares of Revolution Medicines (United States)15
- Mar 1, 2024Shares withheld for tax 323 shares at $75.88 of International Flavors & Fragrances10
- Mar 1, 2024Exercised options 1,324 shares of International Flavors & Fragrances10
- Mar 1, 2023Shares withheld for tax 477 shares at $91.64 of International Flavors & Fragrances16
- Mar 1, 2023Exercised options 1,323 shares of International Flavors & Fragrances16
- Nov 1, 2021Sold 39,762 shares at $87.87 of Merck & Co.7
- Nov 1, 2021Exercised options 19,847 shares of Merck & Co.7
- Nov 1, 2021Exercised options 19,915 shares of Merck & Co.7
- Oct 30, 2021Shares withheld for tax 1,162 shares at $88.05 of Merck & Co.7
- Oct 30, 2021Exercised options 2,358 shares at $88.05 of Merck & Co.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCencora, Board member
- 3
- 4
- 5
- 6SEC EDGARDuPont, Board member
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 30, 2025
- 12SEC EDGARForm 5 filed Jan 16, 2026
- 13SEC EDGARForm 4 filed Mar 10, 2025
- 14SEC EDGARForm 4 filed Nov 5, 2024
- 15SEC EDGARForm 4 filed Aug 7, 2024
- 16SEC EDGARForm 4 filed Mar 2, 2023